ClinicalTrials.gov record
Completed Phase 2 Interventional

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

ClinicalTrials.gov ID: NCT00087113

Public ClinicalTrials.gov record NCT00087113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 12:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation Of Pemetrexed (ALIMTA, LY231517, IND #40061) In the Treatment Of Recurrent Carcinoma Of The Cervix

Study identification

NCT ID
NCT00087113
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • pemetrexed disodium Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2004
Primary completion
May 31, 2006
Completion
Not listed
Last update posted
Feb 13, 2014

Started 2004

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Doctors Medical Center Modesto California 95350-4138
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford Connecticut 06105
Hinsdale Hematology Oncology Associates Hinsdale Illinois 60521
CCOP - Kansas City Kansas City Missouri 64131
St. John's Regional Health Center Springfield Missouri 65804
Women's Cancer Center - Las Vegas Las Vegas Nevada 89102
SUNY Downstate Medical Center Brooklyn New York 11203
SUNY Upstate Medical University Hospital Syracuse New York 13210
Hope A Women's Cancer Center Asheville North Carolina 28801
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295
Case Comprehensive Cancer Center Cleveland Ohio 44106
MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland Ohio 44109
Hillcrest Cancer Center at Hillcrest Hospital Mayfield Heights Ohio 44124
Oklahoma University Medical Center Oklahoma City Oklahoma 73104
Cancer Care Associates - Midtown Tulsa Tulsa Oklahoma 74104
Williamette Gynecologic Oncology P.C. Salem Oregon 97301
Rosenfeld Cancer Center at Abington Memorial Hospital Abington Pennsylvania 19001
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania 18105
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas 75390
M.D. Anderson Cancer Center at University of Texas Houston Texas 77030-4009
Massey Cancer Center at Virginia Commonwealth University Richmond Virginia 23298-0037

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2014 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00087113 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →